Buchumschlag

Elucidating the beneficial impact of exercise on chronic obstructive pulmonary disease and its comorbidities: Integrating proteomic and immunological insights

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Xishuai Wang, Cong Liu, Ruining Liang, Yuehui Zhou, Xiliang Kong, Weichao Wang, Hongwei Wang, Lunan Zhao, Weina Niu, Chao Yi, Fugao Jiang
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2024
Schlagworte:	British Journal of Pharmacology
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Population pharmacokinetic/target engagement modelling of tozorakimab in healthy volunteers and patients with chronic obstructive pulmonary disease
von: Muhammad Waqas Sadiq, et al.
Veröffentlicht: (2024)

Exploring drug mechanisms through single‐cell proteomics
von: Yuzhi Sun, et al.
Veröffentlicht: (2026)

Role of monocarboxylate transporters in cancer immunology and their therapeutic potential
von: Ferdos Faghihkhorasani, et al.
Veröffentlicht: (2025)

Beyond TGFβ inhibition: Chitosan oligosaccharide targets PGC‐1α‐mediated mitochondrial repair to combat pulmonary fibrosis
von: Huan He, et al.
Veröffentlicht: (2025)

Elucidation of the zinc binding site in KCNQ channels
von: Shuo Zhang, et al.
Veröffentlicht: (2025)

Biased agonists of GPR84 and insights into biological control
von: Vincent B. Luscombe, et al.
Veröffentlicht: (2024)

Inhibition of GRK2 mitigates cisplatin‐induced acute and chronic nephrotoxicity by targeting the NADPH oxidase 4/oxidative stress axis
von: Fei Duan, et al.
Veröffentlicht: (2026)

Deacetylation of BAP31 by sirtuin 2 attenuates apoptosis of hepatocytes induced by endoplasmic reticulum stress, in chronic alcoholic liver injury
von: Sai Wang, et al.
Veröffentlicht: (2025)

Corticosteroid insensitivity in asthma associated with obstructive sleep apnoea: Role of oxidative stress and histone acetylation
von: Chun‐Yu Lo, et al.
Veröffentlicht: (2025)

6‴‐Feruloylspinosin ameliorates pressure overload‐induced heart failure with comorbid insomnia through the activation of RORα
von: Yan Yan, et al.
Veröffentlicht: (2025)

Glial modulators as novel therapeutics for comorbid pain and opioid use disorder
von: Elizabeth K. C. Schwartz, et al.
Veröffentlicht: (2024)

S1P/S1PRs‐TRPV4 axis is a novel therapeutic target for persistent pain and itch in chronic dermatitis
von: Xinyu Zhang, et al.
Veröffentlicht: (2024)

The sodium–glucose co‐transporter 2 inhibitor, empagliflozin, attenuates pulmonary vascular remodelling by inhibiting the phosphorylation of PDGF receptor‐β
von: Ting‐ting Lyu, et al.
Veröffentlicht: (2025)

Sex‐related susceptibility to pulmonary fibrosis development in mice
von: Danilo D'Avino, et al.
Veröffentlicht: (2026)

Gut microbiota–derived trimethylamine‐N‐oxide protects pulmonary vascular barrier integrity via Vav guanine nucleotide exchange factor 3 (VAV3)‐mediated cytoskeletal remodelling in acute lung injury
von: Xilong Wang, et al.
Veröffentlicht: (2026)

Development of a long‐acting relaxin for the treatment of pulmonary hypertension
von: John Diener, et al.
Veröffentlicht: (2026)

Effects of age, sex, daily dose, comorbidity and co‐medication on venlafaxine‐associated cardiovascular adverse events: A pharmacovigilance analysis of the FDA Adverse Event Reporting System database
von: Zhanzhang Wang, et al.
Veröffentlicht: (2024)

Polypharmacy in mice disrupts left ventricular function and structure and promotes proteome reorganisation in an age‐ and sex‐specific fashion
von: Trang Tran, et al.
Veröffentlicht: (2025)

Psilocybin as a novel treatment for chronic pain
von: Tate Askey, et al.
Veröffentlicht: (2024)

TREM2 activation suppresses central sensitisation by promoting autophagy in a chronic migraine model with recurrent nitroglycerin stimulation in mice
von: Suifa Hu, et al.
Veröffentlicht: (2026)

First‐in‐human assessment of safety and pharmacokinetics of EP9001A:an anti‐nerve growth factor antibody for chronic pain treatment
von: Yue Cheng, et al.
Veröffentlicht: (2025)

The TREK‐1 potassium channel is a potential pharmacological target for vasorelaxation in pulmonary hypertension
von: Réka Csáki, et al.
Veröffentlicht: (2024)

Resolution of inflammation in pulmonary arterial hypertension, the influence of sex—An IUPHAR immunopharmacology committee review
von: Chloe Landy, et al.
Veröffentlicht: (2025)

Involvement of the somatosensory‐autonomic reflex and muscarinic receptors in exacerbation of allergic pulmonary inflammation by electroacupuncture
von: Shuyan Liu, et al.
Veröffentlicht: (2025)

Cytochrome P450 1A1 influences obesity‐induced pulmonary hypertension
von: Joshua P. Dignam, et al.
Veröffentlicht: (2025)

Drug‐likeness evaluation and inhibitory mechanism of the emodin derivative on cardiac fibrosis based on metastasis‐associated protein 3
von: Heng Liu, et al.
Veröffentlicht: (2025)

Correction to “AQX‐1125, small molecule SHIP1 activator inhibits bleomycin‐induced pulmonary fibrosis”
Veröffentlicht: (2024)

An antisense oligonucleotide targeting the heat‐shock protein HSPB5 as an innovative therapeutic approach in pulmonary fibrosis
von: Pierre‐Marie Boutanquoi, et al.
Veröffentlicht: (2025)

Innovative pharmacotherapy for hepatic metabolic and chronic inflammatory diseases in China
von: Feng Zhang, et al.
Veröffentlicht: (2024)

Novel therapeutic targets for chronic visceral pain in gastrointestinal disorders
von: Fleur Veldman, et al.
Veröffentlicht: (2026)

Association between reversal agents (sugammadex vs. neostigmine) for neuromuscular block and postoperative pulmonary complications: A retrospective analysis
von: Aolin Ren, et al.
Veröffentlicht: (2024)

Correction to An antisense oligonucleotide targeting the heat‐shock protein HSPB5 as an innovative therapeutic approach in pulmonary fibrosis
Veröffentlicht: (2025)

Myo‐inositol trispyrophosphate prevents right ventricular failure and improves survival in monocrotaline‐induced pulmonary hypertension in the rat
von: Marta Oknińska, et al.
Veröffentlicht: (2024)

Repurposing SGLT2 and DPP‐4 inhibitors for mild cognitive impairment in type 2 diabetes mellitus: Insights from proteomics, target prediction and molecular docking
von: Shams T. Osman, et al.
Veröffentlicht: (2026)

Targeting IL‐11 to reduce fibrocyte circulation and lung accumulation in animal models of pulmonary hypertension‐associated lung fibrosis
von: Javier Milara, et al.
Veröffentlicht: (2024)

To CB2 or not CB2: Revisiting renoprotection in acute and chronic kidney injury
von: Jonathan M. de Jesus, et al.
Veröffentlicht: (2025)

Novel approaches for drug development against chronic primary pain: A systematic review
von: Valéria Tékus, et al.
Veröffentlicht: (2025)

MicroRNA‐guided drug discovery for mitigating persistent pulmonary complications in critical COVID‐19 survivors: A longitudinal pilot study
von: María C. García‐Hidalgo, et al.
Veröffentlicht: (2024)

Cannabinoid CB2 receptor‐mediated analgesia: mechanism‐based insights and therapeutic potential
von: Kelsey G. Guenther, et al.
Veröffentlicht: (2025)

Acetazolamide‐induced pulmonary oedema: A disproportionality analysis from the EudraVigilance database
von: Montserrat García, et al.
Veröffentlicht: (2024)